In psoriasis lesions, a diverse mixture of cytokines is up-regulated that influence each other
generating a complex inflammatory situation. Although this is the case, the inhibition of IL …

Psoriasis is a chronic relapsing, remitting interleukin (IL)-23/IL-17-driven skin disease
mediated by the interplay of T cells and polymorphonuclear granulocytes. Although …

Psoriasis, a multisystem chronic disease characterized by abnormal keratinocyte
proliferation, has an unclear pathogenesis where systemic inflammation and oxidative stress …

Biological agents including anti-tumor necrosis factor (anti-TNF; adalimumab, infliximab,
etanercept) and anti-interleukin-12/13 (IL12/23; ustekinumab) are essential for treatment of …

The 21st century has seen a substantial increase in the industrial applications of glycolipid
biosurfactant technology. The market value of the glycolipid class of molecules …

Psoriasis is characterized by raised, scaly, well‑demarcated, erythematous oval plaques.[1]
Although studies have revealed that disruption of immune tolerance and excessive …

Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual
Immune Profile Assessment in Patients with Psoriasis - PMC Back to Top Skip to main content …

Psoriasis is a chronic inflammatory skin disease that causes erythema, scale, and invasion
due to excessive proliferation of keratinocyte and vascular deformation of the upper part of …

Background There remains an unmet need for oral medications that are safe and efficacious
for long‐term management of chronic inflammatory skin diseases (CISD). Inhibition of …

Preparations containing calcipotriol combined with betamethasone dipropionate (in the
forms of ointment, gel, and foam) are available for the topical treatment of psoriasis. This …